Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review.
CD30
anaplastic large cell lymphoma
anaplastic lymphoma kinase
central nervous system
primary central nervous system lymphoma
prognostic factors
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
28 Aug 2021
28 Aug 2021
Historique:
received:
01
08
2021
revised:
21
08
2021
accepted:
23
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
11
9
2021
Statut:
epublish
Résumé
Primary anaplastic large cell lymphoma (ALCL) of the central nervous system (CNS) is a subtype of primary CNS lymphoma (PCNSL). There are very few comprehensive reports on this extremely rare tumor. Therefore, it is necessary to investigate the clinical features and prognostic factors for primary ALCL of the CNS. We performed a systematic review of the published literature. Past cases were comprehensively searched using PubMed, Cochrane Library, and Web of Science. Clinical information, such as age, sex, anaplastic lymphoma kinase (ALK) status, lesion sites, treatment methods, and survivorship were extracted. Thirty-nine cases with information on ALK status and treatment course were identified. The average observation period was 13 months, and the overall 2-year survival rate was 58%. Univariate analyses showed a statistically significantly better prognosis among patients < 40 years of age (
Identifiants
pubmed: 34503168
pii: cancers13174358
doi: 10.3390/cancers13174358
pmc: PMC8431692
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Ministry of Education, Culture, Sports, Science and Technology.
ID : B; No. 21H03041
Organisme : Ministry of Education, Culture, Sports, Science and Technology.
ID : C; No. 19K09473
Références
Br J Neurosurg. 2020 Nov 30;:1-6
pubmed: 33253051
Cancer. 2000 Sep 15;89(6):1359-70
pubmed: 11002232
Medicine (Baltimore). 2016 Dec;95(49):e5534
pubmed: 27930548
J Cancer Res Ther. 2015 Oct-Dec;11(4):943-5
pubmed: 26881551
J Natl Cancer Inst. 1996 May 15;88(10):675-9
pubmed: 8627644
Pediatr Neurosurg. 2007;43(6):516-21
pubmed: 17992044
Crit Rev Oncol Hematol. 2013 Feb;85(2):206-15
pubmed: 22789917
Lancet. 2009 Oct 31;374(9700):1512-20
pubmed: 19767089
Arch Pathol Lab Med. 2008 Nov;132(11):1830-4
pubmed: 18976024
Neuro Oncol. 2016 Oct 1;18(suppl_5):v1-v75
pubmed: 28475809
J Pediatr Hematol Oncol. 2008 Dec;30(12):963-7
pubmed: 19131793
Pediatr Neurosurg. 1998 Nov;29(5):250-2
pubmed: 9917542
World Neurosurg. 2020 Jul;139:415-418
pubmed: 32360734
Br J Cancer. 2011 Oct 25;105(9):1414-8
pubmed: 21915121
Insights Imaging. 2019 Feb 6;10(1):11
pubmed: 30725238
Hum Pathol. 1999 Aug;30(8):978-81
pubmed: 10452512
BMJ Case Rep. 2011 Feb 24;2011:
pubmed: 22707580
Acta Neurochir (Wien). 2015 Feb;157(2):187-94
pubmed: 25488176
Am J Clin Pathol. 1995 Apr;103(4):496-9
pubmed: 7726150
Neurology. 2002 May 28;58(10):1513-20
pubmed: 12034789
J Postgrad Med. 2005 Oct-Dec;51(4):326-7
pubmed: 16388180
Arch Pathol Lab Med. 2004 Mar;128(3):324-7
pubmed: 14987153
J Clin Oncol. 2012 Nov 10;30(32):3939-46
pubmed: 23045585
Int J Clin Exp Pathol. 2013 Jul 15;6(8):1643-51
pubmed: 23923083
Hum Pathol. 1994 Nov;25(11):1253-6
pubmed: 7959674
Nat Clin Pract Neurol. 2007 Jan;3(1):24-35
pubmed: 17205072
Yonsei Med J. 2013 May 1;54(3):791-6
pubmed: 23549832
Ann Oncol. 2002 Nov;13(11):1827-32
pubmed: 12419758
J Clin Oncol. 2013 Nov 1;31(31):3971-9
pubmed: 24101038
Mol Clin Oncol. 2013 Jul;1(4):655-660
pubmed: 24649224
J Clin Oncol. 2003 Mar 15;21(6):1044-9
pubmed: 12637469
J Neurooncol. 2018 Feb;136(3):577-583
pubmed: 29147860
J Neurosurg Pediatr. 2014 Sep;14(3):311-5
pubmed: 25014324
Pediatr Blood Cancer. 2010 Dec 1;55(6):1227-30
pubmed: 20882580
Ann Oncol. 1997 Mar;8(3):227-34
pubmed: 9137790
World Neurosurg. 2020 Jun;138:169-173
pubmed: 32151774
Am J Surg Pathol. 2003 Apr;27(4):487-93
pubmed: 12657933
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420941756
pubmed: 32664812
Pathology. 2003 Oct;35(5):451-2
pubmed: 14555393
Ann Nucl Med. 2014 Aug;28(7):603-9
pubmed: 24743915
Neuro Oncol. 2019 Feb 19;21(3):296-305
pubmed: 30418592
Pathol Res Pract. 2001;197(9):647-52
pubmed: 11569930
Mol Cell Biol. 1997 Apr;17(4):2312-25
pubmed: 9121481
Blood. 1985 Oct;66(4):848-58
pubmed: 3876124
Clin Neuropathol. 2006 Sep-Oct;25(5):232-6
pubmed: 17007446
Cancer. 2017 Nov 15;123(22):4314-4324
pubmed: 28950405
Medicine (Baltimore). 2020 Jul 17;99(29):e21115
pubmed: 32702861
Neuropathology. 2010 Jun;30(3):260-6
pubmed: 19751246
Brain Tumor Pathol. 2013 Jan;30(1):61-5
pubmed: 22426596
Adv Anat Pathol. 2015 Jan;22(1):29-49
pubmed: 25461779
Neurol India. 2017 Mar-Apr;65(2):402-405
pubmed: 28290414
Blood. 2000 Nov 1;96(9):2993-3000
pubmed: 11049976
Pediatr Neurosurg. 2015;50(3):145-51
pubmed: 25896198
Cancer Cell. 2015 Apr 13;27(4):516-32
pubmed: 25873174
Science. 1994 Mar 4;263(5151):1281-4
pubmed: 8122112
Hematol Oncol Stem Cell Ther. 2014 Dec;7(4):157-61
pubmed: 25066795
Med Arch. 2016 Jul 27;70(4):311-313
pubmed: 27703297
J Pediatr Hematol Oncol. 2009 Feb;31(2):128-30
pubmed: 19194199
Clin Radiol. 2017 Sep;72(9):722-728
pubmed: 28554578
Mil Med. 2007 Jun;172(6):673-5
pubmed: 17615857
Leuk Lymphoma. 2003 Jul;44(7):1243-5
pubmed: 12916880
Cancer Causes Control. 2019 May;30(5):477-488
pubmed: 30888569
J Clin Exp Hematop. 2017;57(3):120-142
pubmed: 29279550
Neuropathology. 2009 Apr;29(2):166-71
pubmed: 18564100
Neuro Oncol. 2012 Dec;14(12):1481-4
pubmed: 22984018